首页>
外国专利>
Anti-VEGFR2 human antibodies for anti-angiogenesis and targeted cancer therapy
Anti-VEGFR2 human antibodies for anti-angiogenesis and targeted cancer therapy
展开▼
机译:抗VEGFR2人类抗体,用于抗血管生成和靶向癌症治疗
展开▼
页面导航
摘要
著录项
相似文献
摘要
Disclosed are isolated antibodies or antigen-binding fragments thereof having a specific binding affinity for an epitope located within domain 1 or domain 3 of human vascular endothelial growth factor receptor 2 (VEGFR2; SEQ ID NO: 74). The epitope inside domain 3 of VEGFR2 is located between amino acid residues 250 and 270 of SEQ ID NO: 74. In the manufacture of a medicament for inhibiting / inhibiting tumor growth, tumor angiogenesis or inducing cancer cell cytotoxicity in a subject in need of tumor growth, inhibition of tumor angiogenesis and / or induction of cancer cell cytotoxicity, The use of the antibody or antigen-binding fragment thereof is also disclosed. Also disclosed is a method for detecting the presence of VEGFR2 in tumor vascular endothelial cells or cancer cells in a biological sample.
展开▼
机译:公开了对位于人血管内皮生长因子受体2(VEGFR2; SEQ ID NO:74)的结构域1或结构域3内的表位具有特异性结合亲和力的分离的抗体或其抗原结合片段。 VEGFR2的结构域3内的表位位于SEQ ID NO:74的氨基酸残基250和270之间。在制造用于抑制/抑制需要肿瘤的受试者的肿瘤生长,肿瘤血管生成或诱导癌细胞细胞毒性的药物时生长,抑制肿瘤血管生成和/或诱导癌细胞的细胞毒性。还公开了抗体或其抗原结合片段的用途。还公开了一种用于检测生物样品中的肿瘤血管内皮细胞或癌细胞中VEGFR2的存在的方法。
展开▼